Codexis (CDXS) Other financing activities (2010 - 2026)
Codexis (CDXS) posted quarterly Other financing activities of $781000.0 for Q4 2025, up 113.97% year-over-year from $365000.0 in Q4 2024, and up 200.0% quarter-over-quarter from -$781000.0 in Q2 2025.
Codexis (CDXS) Other financing activities (2010 - 2026) Analysis & Trends
Codexis' Other financing activities history runs 16 years deep, the most recent figure standing at $781000.0 for Q4 2025.
- In Q4 2025, Other financing activities rose 113.97% year-over-year to $781000.0; the TTM figure through Dec 2025 stood at $1.1 million (up 69.97% YoY), while the FY2025 annual figure was $1.1 million, up 69.97% from the prior year.
- Other financing activities for Q4 2025 stood at $781000.0, up from -$781000.0 in the prior quarter.
- The five-year high for Other financing activities was $2.7 million in Q3 2021, with the low at -$2.5 million in Q4 2021.
- The 5-year median for Other financing activities is $211000.0 (2023), against an average of $161444.4.
- The sharpest annual moves came in 2021 and 2025: Other financing activities soared 2976.92% in 2021, then plunged 1797.83% in 2025.
- Codexis' Other financing activities stood at -$2.5 million in 2021, then jumped by 136.62% to $913000.0 in 2022, then plunged by 146.22% to -$422000.0 in 2023, then jumped by 186.49% to $365000.0 in 2024, then jumped by 113.97% to $781000.0 in 2025.
- Business Quant data shows CDXS's Other financing activities at $781000.0 in Q4 2025, -$781000.0 in Q2 2025, and $1.1 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - |
| 10 | Codexis | 152.51 Mn | 97.60 Mn | 11.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 148,000.00 |
| Jun 30, 2026 | 148,000.00 |
| Dec 31, 2025 | 781,000.00 |
| Dec 31, 2025 | 781,000.00 |
| Jun 30, 2025 | -781,000.00 |
| Jun 30, 2025 | -781,000.00 |
| Mar 31, 2025 | 1.10 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 365,000.00 |
| Dec 31, 2024 | 365,000.00 |
| Sep 30, 2024 | -46,000.00 |
| Sep 30, 2024 | -46,000.00 |
| Jun 30, 2024 | 46,000.00 |
| Jun 30, 2024 | 46,000.00 |
| Mar 31, 2024 | 281,000.00 |
| Mar 31, 2024 | 281,000.00 |
| Dec 31, 2023 | -422,000.00 |
| Dec 31, 2023 | -422,000.00 |
| Jun 30, 2023 | 141,000.00 |
| Jun 30, 2023 | 141,000.00 |